• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Supporting HIV-affected couples trying to conceive

Bioengineer by Bioengineer
April 4, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A pilot study identifies a safe, effective strategy to help women with HIV have children in low-resource countries

IMAGE

Credit: Michigan Medicine

ANN ARBOR, Mich. – Women with HIV were once advised against having children for fear that the infection could be passed on to their babies.

But medical advancements are not only allowing people with HIV to live longer and fuller lives — but to grow their families, too.

Timed vaginal insemination is a safe, effective way to help HIV-affected couples conceive, finds a new pilot study in Kenya led by a Michigan Medicine researcher and published in the PLOS ONE.

Among 23 couples, in which the woman was HIV-positive and the man was not, timed vaginal insemination led to six live births without a case of HIV transmission.

“People who are living with a stable HIV infection are focused on fully integrating into their communities and living productive lives,” says lead author Okeoma Mmeje, M.D., assistant professor of obstetrics and gynecology at Michigan Medicine. Mmeje conducted the study while at the University of California, San Francisco.

“HIV does not change an individual’s desire to have children,” she says. “Our study describes a feasible, safe and effective method for women living with HIV to achieve pregnancy.”

HIV-serodiscordant

In sub-Saharan Africa, women disproportionately represent the majority of new HIV infections. An estimated 44 percent of couples in Kenya are HIV-serodiscordant, in which one partner is infected by HIV and the other is not. But about 20 to 50 percent of HIV-infected people still want to have children, according to previous research.

Current guidelines recommend antiretroviral treatment in HIV-serodiscordant couples — the therapy helps keep HIV at low levels, keeping people healthy for longer and reducing the risk of spreading HIV to others.

But the effectiveness of antiretroviral therapy may not be routinely assessed or guaranteed with an undetectable HIV viral load, authors say.

“We know there’s a strong desire among many HIV-affected couples to have children but that current strategies to suppress the virus may be inadequate,” says Mmeje, who is also a member of the U-M Institute for Healthcare Policy and Innovation.

“More options to support safely becoming pregnant should be offered to these couples and integrated into HIV prevention programs,” she says.

Mmeje says health care providers caring for HIV-serodiscordant couples should also consider offering them a fertility evaluation before attempting to conceive or after several unsuccessful attempts.

Study participants were recruited from eight HIV care and treatment clinics in the Kisumu area of Western Kenya and included women ages 18 to 34. Instructional aids were used for the procedures, education and counseling sessions.

Couples were observed for two months before timed vaginal insemination and were tested and treated for sexually transmitted infections. Timed vaginal insemination was performed for up to six menstrual cycles, and a fertility evaluation was offered to couples who did not become pregnant.

Mmeje notes that the method and best practices described in the pilot study could be implemented by HIV prevention programs globally.

“Our findings are applicable to low-resource environments throughout the world,” she says. “This strategy could have high impact on empowering HIV-affected women with an affordable and readily accessible reproductive option that supports their desire to have children.”

###

Media Contact
Beata Mostafavi
[email protected]

Original Source

http://michmed.org/e7paK

Related Journal Article

http://dx.doi.org/10.1371/journal.pone.0212656

Tags: AIDS/HIVBehaviorFertilityMedicine/HealthPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Boosting ADMET Predictions for Key CYP450s

Boosting ADMET Predictions for Key CYP450s

August 2, 2025
blank

Fermentable Carbs and Metformin Boost Prediabetes Control

August 2, 2025

TLR4 and ILC2 Drive Persistent Airway Type 2 Immunity

August 2, 2025

Hybrid Approach Detects Ballistocardiogram Motion Artifacts

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    44 shares
    Share 18 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Boosting ADMET Predictions for Key CYP450s

Saliva Exosome Proteins and Lipids Diagnose Esophageal Cancer

Feasibility of Range-Compensated Proton Arc Therapy

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.